The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors
Abstract
Adaptation to hypoxia is critical for survival and regulates multiple processes, including erythropoiesis and vasculogenesis. Chuvash polycythemia is a hypoxia-sensing disorder characterized by homozygous mutation (598C>T) of von Hippel-Lindau gene (VHL), a negative regulator of hypoxia sensing. Although endemic to the Chuvash population of Russia, this mutation occurs worldwide and originates from a single ancient event. That VHL 598C>T homozygosity causes elevated normoxic levels of the transcription factor hypoxia inducible factor-1α (HIF-1α), serum erythropoietin and hemoglobin is known, but the disease phenotype has not been documented in a controlled manner. In this matched cohort study, VHL 598C>T homozygosity was associated with vertebral hemangiomas, varicose veins, lower blood pressures, and elevated serum vascular endothelial growth factor (VEGF) concentrations (P < .0005), as well as premature mortality related to cerebral vascular events and peripheral thrombosis. Spinocerebellar hemangioblastomas, renal carcinomas, and pheochromocytomas typical of classical VHL syndrome were not found, suggesting that overexpression of HIF-1α and VEGF is not sufficient for tumorigenesis. Although hemoglobin-adjusted serum erythropoietin concentrations were approximately 10-fold higher in VHL 598C>T homozygotes than in controls, erythropoietin response to hypoxia was identical. Thus, Chuvash polycythemia is a distinct VHL syndrome manifested by thrombosis, vascular abnormalities, and intact hypoxic regulation despite increased basal expression of hypoxia-regulated genes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To explain the observed suppression of hepcidin, we considered the possibility that testosterone suppresses the cytokine interleukin-6, a known positive regulator of hepcidin (23).”
From Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point (2014) · cites this paper as [23]
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Lonser, R. R., Glenn, G. M., Walther, M. M., Chew, E. Y., Libutti, S. K., Linehan, W. M., & Oldfield, E. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13643-4 · Cited by 1,630
Nitric oxide synthases: which, where, how, and why?
Michel, T. M., & Féron, O. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119750 · Cited by 1,024
Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology
Semenza, G. L. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02090-1 · Cited by 930
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00043-0 · Cited by 761
Erythropoietin: Physiology and Pharmacology Update
Fisher, J. W. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800101 · Cited by 707
VEGF Gene Delivery to Myocardium
Lee, R. J., Springer, M. L., Blanco-Bose, W. E., Shaw, R. M., Ursell, P. C., & Blau, H. M. (2000) · Circulation · doi:10.1161/01.cir.102.8.898 · Cited by 696
Diagnosis and classification of the polycythemias.
Berlin, N. I. (1975) · PubMed · Cited by 557
Declerck, P. J., Alessi, M., Verstreken, M. F. K., Kruithof, E. K. O., Juhan-Vague, I., & Collen, D. (1988) · Blood · doi:10.1182/blood.v71.1.220.220 · Cited by 537
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
Ang, S. O., Chen, H., Hirota, K., Gordeuk, V. R., Jelinek, J., Guan, Y., Liu, E., Sergueeva, A. I., Miasnikova, G. Y., Mole, D., et al. (2002) · Nature Genetics · doi:10.1038/ng1019 · Cited by 510
Self-citation
Research works printed but not linked: 1
- Jaakola P, Mole DR, Tian YM, et al. Targeting of HIF-alpha to the von Hippel Lindau ubiqutiylation complex by O2-regulated hydroxylation. Science. 2001;292: 48-72.
Cited by
Sorted by citations
Items 201–275 of 275
The high oxygen affinity haemoglobin Nantes: a family case description.
Artuso, A., Balter, R., Bonetti, E., Zambon, C., Ravani, A., Dolcini, B., Masieri, M. T., Salvagno, G. L., Zanotti, R., Pizzolo, G., et al. (2015) · PubMed Central · doi:10.2450/2014.0206-14 · Cited by 3
The boy with the ruddy face: An approach to polycythaemia presenting in childhood
Lam, J. C. M., Campbell, S., & Barnes, C. D. (2017) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.13820 · Cited by 3
Polyglobulie rare par mutation du gène EGLN1 : à propos d’un cas et revue de la littérature
Bonnin, A., Gardie, B., Girodon, F., Airaud, F., Garrec, C., Bezieau, S., Vignon, G., Mottaz, P., Labrousse, J., & Lellouche, F. (2020) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2019.12.019 · Cited by 3
Interrelationships Among Hypoxia-Inducible Factor Biology and Acid-Base Equilibrium
Hulter, H. N., & Krapf, R. (2006) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2006.10.006 · Cited by 3
Mathur, S. C., Schexneider, K. I., & Hutchison, R. E. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00031-2 · Cited by 3
Pulmonary hypertension with warm hands
Botros, L., Aman, J., Bogaard, H. J., & Noordegraaf, A. V. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-209982 · Cited by 3
Alkaissi, H. R., Cole, Y., Doucet-O’Hare, T. T., Rosenblum, J. S., Zhuang, Z., & Pacák, K. (2025) · Communications Medicine · doi:10.1038/s43856-025-01039-7 · Cited by 2
Expanding the clinical tumor phenotype of the EPAS1 -asssociated tumor syndrome
Cole, Y., Howarth, S., Javaid, A., Tarpey, P. S., Scoffings, D. J., Maher, E. R., Godfrey, A. L., Pacák, K., Zhuang, Z., Alkaissi, H. R., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag003 · Cited by 2
Yeşilaltay, A., Degirmenci, H., Bilgen, T., Şirin, D. Y., Garbioglu, D. B., Degirmenci, P., Tekinalp, A., Alpsoy, Ş., Okuturlar, Y., & Turgut, B. (2022) · Medicine · doi:10.1097/md.0000000000029881 · Cited by 2
Hypogonadotrophic hypogonadism due to intrasellar hemangioblastoma in von Hippel–Lindau syndrome
Barton, J. C., Gonçalves, E., Santani, A., Chandra‐Sekar, B., Morris, E. C., Carter, B. B., & Stolle, C. A. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32698 · Cited by 2
Erythropoiesis—genetic abnormalities
Prchal, J. T., & Gregg, X. T. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8698-6_4 · Cited by 2
Self-citationvon Hippel-Lindau syndrome-related congenital polycythemia and response to belzutifan
Amaral, P. S., Mohan, S. R., & Beckermann, K. E. (2024) · Haematologica · doi:10.3324/haematol.2024.285724 · Cited by 3
Jacob, P. (2014) · Springer eBooks · doi:10.1007/978-81-322-1991-0_5 · Cited by 2
Erythropoietin‐secreting metanephric adenoma presenting as erythrocytosis
Liu, A., Kremyanskaya, M., Mehrazin, R., Si, Q., Robinson, B. D., Cushing, M. M., Hoffman, R., & Ginzburg, Y. Z. (2023) · American Journal of Hematology · doi:10.1002/ajh.27047 · Cited by 1
Vhl deletion in Dmp1-expressing cells alters MEP metabolism and promotes stress erythropoiesis
Emery, J., Chicana, B. J., Taglinao, H., Ponce, C., Donham, C., Padmore, H., Sebastian, A., Trasti, S., & Manilay, J. O. (2024) · Frontiers in Hematology · doi:10.3389/frhem.2023.1276426 · Cited by 1
VHL, transferrin, and erythropoietin in the regulation of hepcidin
Sergeev, I., Prchal, J. T., Nouraie, S. M., Shah, B. N., Zhang, X., Sergueeva, A., Miasnikova, G., Ganz, T., & Gordeuk, V. R. (2025) · HemaSphere · doi:10.1002/hem3.70271 · Cited by 1
Self-citationPrchal, J. T. (2012) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2012.10.014 · Cited by 1
Self-citationHb Heathrow [β103(G5)Phe→Leu], a First Report in an Asian Patient with Erythrocytosis
Shin, S.-Y., Kim, H., Kim, H., & Kim, H. (2017) · Yonsei Medical Journal · doi:10.3349/ymj.2017.58.3.665 · Cited by 2
A Teenager With Migraines, Plethora, and Conjunctival Injection
Razvi, R., & Berman, B. (2022) · Clinical Pediatrics · doi:10.1177/00099228221112051 · Cited by 1
Clinical Implications of Germline Pathogenic Variants in the VHL Gene
Friedman, E. (2024) · Springer eBooks · doi:10.1007/978-3-031-53858-2_1 · Cited by 1
Halperin, R., Horwitz, R., Schwarz, Y., & Tirosh, A. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02799-1 · Cited by 1
New molecules and formulations
Elliott, S. G. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8698-6_8 · Cited by 1
Missense Mutation in Cancer in Correlation to Its Phenotype – VHL as a Model
AlFadhli, S. M. (2012) · InTech eBooks · doi:10.5772/36727 · Cited by 1
Novel mutations in the von Hippel–Lindau gene associated with congenital polycythemia
Sidhu, A., Bhambhani, K. J., & Callaghan, M. U. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25407 · Cited by 1
The Genetic Base of Chronic Venous Disease: a Review of Modern Concepts
Smetanina, M. A., Shadrina, A. S., Zolotukhin, I. A., & Filipenko, M. I. (2016) · Journal of Venous Disorders · doi:10.17116/flebo2016104199-213 · Cited by 1
Franke, K., Kalucka, J. M., Mamlouk, S., Singh, R. P., Muschter, A., Weidemann, A., Iyengar, V., Jahn, S., Wieczorek, K. S., Geiger, K. D., et al. (2017) · Cited by 1
Pregnancy with Chuvash Polycythaemia and Other Congenital Erythrocytosis
Dewarrat, N., Kaiser, J., Baud, D., Alberio, L., & Gavillet, M. (2019) · Acta Haematologica · doi:10.1159/000499861 · Cited by 1
Hypoxic Response and Associated Diseases
Flashman, E., Loenarz, C., & Schofield, C. J. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb232 · Cited by 1
Polycythemia Vera and Other Polycythemic Disorders — Biological Aspects
Ang, S., & Prchal, J. T. (2007) · Springer eBooks · doi:10.1007/978-3-540-34506-0_17 · Cited by 1
Self-citationEffects of hydralazine on the pulmonary vasculature and respiratory control in humans
Chun, L., Balanos, G. M., Fatemian, M., Smith, T. G., Dorrington, K. L., & Robbins, P. A. (2007) · Experimental Physiology · doi:10.1113/expphysiol.2007.039750 · Cited by 1
BACKGROUND INFORMATION FOR ONCOLOGIC DRUGS ADVISORY COMMITTEE
Oaks, T. (2007) · Cited by 1
POEMS syndrome remains a mystery after 40 years
Wang, C. (2021) · Leukemia · doi:10.1038/s41375-021-01168-7 · Cited by 1
Etablierung und Charakterisierung einer Tetracyclin-induzierbaren PHD2-Knockdown-HeLa-Zelllinie
Le-Huu, S. K.-A. (2010) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-818
Molecular Genetics of Primary Varicose Vein Disease
Adesina-Georgiadis, K. N., Anwar, M., & Davies, A. H. (2013) · Wiley eBooks · doi:10.1002/9780470015902.a0025031
Mesa, J. F. C., Rodríguez-Camacho, D. F., & Correa, J. C. (2015) · Archivos de Medicina (Manizales) · doi:10.30554/archmed.15.1.674.2015
Cade, J. F. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511835278.017
Is a little hypoxia good for you?
Prchal, J. T., & Gordeuk, V. R. (2006) · Blood · doi:10.1182/blood-2005-10-4306
Self-citationNovel strategies for nephroprotection using hypoxia-inducible gene expression
Warnecke, C., Bernhardt, W., Willam, C., Wiesener, M. S., & Eckardt, K. (2007) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2007.07.002
Familial erythrocytosis: molecular links to red blood cell control
Min‐Oo, G., Fortin, A., Tam, M. M., Nantel, A., & Mm, S. (2008)
Koch, C. A., & Majumdar, S. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22480
Ar, R., Slingo, M., Turner, P. J., Christian, H., & Buckler, K. J. (2015)
Oxygen-Dependent Regulation of Erythropoiesis
Haase, V. H. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-857-7_23
JAIN, P. K. (2012) · Medical Case Studies · doi:10.5897/mcs11.031
NAJMAN, A. (2010) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/s1155-1984(10)44580-x
Molecular genetics of the myeloproliferative neoplasms
Beer, P. A. (2016) · Wiley eBooks · doi:10.1002/9781118527948.ch2
Differenzialdiagnose BCR-ABL1-negativer myeloproliferativer Neoplasien
Kvasnicka, H. M., & Grießhammer, M. (2015) · Journal of Laboratory Medicine · doi:10.1515/labmed-2015-0079
Acute hypoxia-induced diaphragm dysfunction is prevented by antioxidant pre-treatment
O’Leary, A. J. (2016) · Arrow@dit (Dublin Institute of Technology)
Current and Novel Drugs for Management of Anemia
Saikumar, J. H., & Kovesdy, C. P. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7360-6_5
Type 2B von Hippel-Lindau disease: molecular biology, tumor growth, and development
Lee, C. M. (2009) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/29tv-bb60
Clinical Characteristics of Pediatric Patients with Congenital Erythrocytosis: A Single-Center Study
Gelen, S. A., Sarper, N., Zengin, E., Tahsin, İ., & Azizoğlu, M. (2021) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-021-01484-z
Brökers, N. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1092
Weiss, M. J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736573711.793577773
(2006) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000193285.71775.eb
Kindliche Knochenmarkerkrankungen
Gattenlöhner, S. (2018) · Springer eBooks · doi:10.1007/978-3-540-85184-4_11
Weiss, M. J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732587239.793577754
Li, J., Luo, X., & Li, P. (2022) · Annals of Hematology · doi:10.1007/s00277-022-04882-z
Chuvash polycythemia in a 53-year-old male: A case report
Hall, T. (2022) · Journal of Case Reports and Images in Oncology · doi:10.5348/100103z10th2022cr
Efficacy of HIF-PH inhibitors in the treatment for renal anemia
坂下, 碧., & 南学, 正. (2022) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.59.263
Step-by-Step Double-Trouble OBAIRH and DMD Diagnosis in a One-Year-Old Boy
Shchagina, O., Kurilova, V. I., Zinina, E., Porubov, V., Efishova, S., & Polyakov, A. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512357
Answers for the CME: Patients with high haemoglobin and negative for JAK2 mutation
Fernandopulle, K. H. B. P. (2022) · The Sri Lanka Journal of Haematology · doi:10.4038/tsljh.v14i1.7
Yeşilaltay, A., & Değirmenci, H. (2024) · The Annals of Clinical and Analytical Medicine · doi:10.4328/acam.22129
Ceyhan‐Birsoy, O., Jayakumaran, G., Kemel, Y. M., Misyura, M., Aypar, U., Jairam, S., Yang, C., Li, Y., Mehta, N. N., Maio, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20495866
Ceyhan‐Birsoy, O., Jayakumaran, G., Kemel, Y. M., Misyura, M., Aypar, U., Jairam, S., Yang, C., Li, Y., Mehta, N. N., Maio, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20495860
Ceyhan‐Birsoy, O., Jayakumaran, G., Kemel, Y. M., Misyura, M., Aypar, U., Jairam, S., Yang, C., Li, Y., Mehta, N. N., Maio, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20495863
II. HIF-PH Inhibitors for the Treatment of Anemia in CKD
Tanaka, T. (2023) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.112.769
Nagy, Z. F., Pfliegler, G., Kosa, J. P., Árvai, K., Istenes, I., Doros, A., Tímár, B., Lakatos, P. L., & Demeter, J. (2025) · Pathology & Oncology Research · doi:10.3389/pore.2025.1612037
Hereditary erythrocytosis in the Chuvash Republic. À literature review
Sergeev, I. I., Burtsev, K. D., & Smetanina, N. S. (2024) · Russian Journal of Pediatric Hematology and Oncology · doi:10.21682/2311-1267-2024-11-2-74-84
Pleyer, L., Neureiter, D., & Greil, R. (2010) · Springer eBooks · doi:10.1007/978-3-211-79892-8_3
Ceyhan‐Birsoy, O., Jayakumaran, G., Kemel, Y. M., Misyura, M., Aypar, U., Jairam, S., Yang, C., Li, Y., Mehta, N. N., Maio, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20495869
Morath, O., Wolfrum, T., Crodel, C. C., Hochhaus, A., Ernst, T., & Rinke, J. (2026) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2026.04.013
Venkatesh, S., Kantharajanna, U. B., Kumble, D., Naik, S. G., & Gopalakrishna, P. (2026) · Journal of Applied Hematology · doi:10.4103/joah.joah_5_26
Alomarı, O., Juhmani, R. A., Güney, B., Sari, M. Y., Salameh, L. B., Alioglu, H., & Tiryaki, M. (2026) · Child s Nervous System · doi:10.1007/s00381-026-07298-6
Classification and Molecular Biology of Polycythemias (Erythrocytoses)
Maran, J., & Prchal, J. T. (2004) · Springer eBooks · doi:10.1007/978-3-642-18738-4_5
Self-citation
Metadata
- Authors
- Gordeuk, V. R., Sergueeva, A. I., Miasnikova, G. Y., Okhotin, D., Voloshin, Y., Choyke, P. L., Butman, J. A., Jedlickova, K., Prchal, J. T., & Polyakova, L. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2004-05-15
- Volume
- 103
- Issue
- 10
- Pages
- 3924-3932
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1979891446
- Cited by
- 273
- References
- 43
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 9 · 2023: 9 · 2022: 18 · 2021: 13 · 2020: 10 · 2019: 10 · 2018: 9 · 2017: 9 · 2016: 15 · 2015: 13 · 2014: 6 · 2013: 14 · 2012: 15
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Digital Howard (Howard University) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL5007-09, UH1-HL03679-05, UH1HL003679, R01HL066333, R01HL66333-01)
- National Center for Research Resources (M01RR010284, M01-RR10284)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- Chuvash polycythemia, von Hippel-Lindau gene, hypoxia sensing, HIF-1α, erythropoietin, thrombosis, vertebral hemangioma, varicose veins, vascular endothelial growth factor, hypoxia adaptation, von Hippel-Lindau disease
- MeSH terms
- Adaptation, Physiological, Adolescent, Adult, Hypoxia, Child, Cross-Sectional Studies, Female, Homozygote, Humans, Male, Mutation, Neoplasms, Polycythemia, Retrospective Studies, Russia, Syndrome, Thrombosis, Transcription Factors, Vascular Diseases, Survival Rate, Tumor Suppressor Proteins, Vascular Endothelial Growth Factor A, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review